Tc-99m Sestamibi uptake in a patient with gynecomastia: A potential pitfall in the diagnosis of breast cancer

Clinical Nuclear Medicine

Volumn 24, Issue 6, 1999, Pages 466-

  Gellett, L R ^a   Farmer, K D ^a   Vivian, G C ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Breast Carcinoma; Gynecomastia; Hormone Replacement Therapy; Hyperparathyroidism; Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIODYSPLASIA; ARTICLE; BREAST CANCER; CASE REPORT; GYNECOMASTIA; HORMONE SUBSTITUTION; HUMAN; KIDNEY FAILURE; MALE; PARATHYROID ADENOMA; PARATHYROID SCINTISCANNING; RADIOISOTOPE DISTRIBUTION; SCINTIMAMMOGRAPHY;

BREAST NEOPLASMS, MALE; DIAGNOSIS, DIFFERENTIAL; GYNECOMASTIA; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0032915115     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199906000-00028     Document Type: Article

References (1)